ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.19M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−281.00
Price / share
$540.48
Trade value
$151.87K
% of position
Common Stock
Shares
−1.16K
Price / share
$541.59
Trade value
$629.86K
% of position
Common Stock
Shares
−456.00
Price / share
$542.68
Trade value
$247.46K
% of position
Common Stock
Shares
−371.00
Price / share
$543.39
Trade value
$201.60K
% of position
Common Stock
Shares
−269.00
Price / share
$544.75
Trade value
$146.54K
% of position
Common Stock
Shares
−825.00
Price / share
$545.87
Trade value
$450.35K
% of position
Common Stock
Shares
−601.00
Price / share
$546.94
Trade value
$328.71K
% of position
Common Stock
Shares
−2.17K
Price / share
$547.83
Trade value
$1.19M
% of position
Common Stock
Shares
−2.04K
Price / share
$548.89
Trade value
$1.12M
% of position
Common Stock
Shares
−1.01K
Price / share
$549.76
Trade value
$554.70K
% of position
Common Stock
Shares
−200.00
Price / share
$550.72
Trade value
$110.14K
% of position
Common Stock
Shares
−120.00
Price / share
$551.50
Trade value
$66.18K
% of position
Net shares
+0.00
Net value
-$4.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/15/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −281.00 | $540.48 | $151.87K | 0.1% | 333.94K | 333.66K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −1.16K | $541.59 | $629.86K | 0.3% | 333.66K | 332.50K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −456.00 | $542.68 | $247.46K | 0.1% | 332.50K | 332.04K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −371.00 | $543.39 | $201.60K | 0.1% | 332.04K | 331.67K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −269.00 | $544.75 | $146.54K | 0.1% | 331.67K | 331.40K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −825.00 | $545.87 | $450.35K | 0.2% | 331.40K | 330.58K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −601.00 | $546.94 | $328.71K | 0.2% | 330.58K | 329.98K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −2.17K | $547.83 | $1.19M | 0.7% | 329.98K | 327.81K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −2.04K | $548.89 | $1.12M | 0.6% | 327.81K | 325.77K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −1.01K | $549.76 | $554.70K | 0.3% | 325.77K | 324.76K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −200.00 | $550.72 | $110.14K | 0.1% | 324.76K | 324.56K |
| Common Stock Indirect | 10/15/2026 | S · Sale | −120.00 | $551.50 | $66.18K | 0.0% | 324.56K | 324.44K |
| Total | +0.00 | -$4.07M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
223.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/15/2026 | M · Option Exercise | −9.50K | 117.76 | — | 223.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.00 | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 8.90K | Indirect |
| Common Stock | 45.60K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |